Conference Proceedings

Updated results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination Lu-177 PSMA 617 and idronoxil in men with mCRPC post androgen signalling inhibition and taxane chemotherapy (LuPIN trial).

Louise Emmett, Sarennya Pathmanandavel, Megan Crumbaker, Christopher Rofe, Andrew On Wah Yam, Bao Ho, Wai Ling Chan, Shikha Sharma, Joanne Keane, Adam James Hickey, Karen Fullard, Kamonwan Kongrak, Lalith Ratnayake, John A Violet, Arun Azad, Peter Eu, Andrew Nguyen, Anthony M Joshua

Journal of Clinical Oncology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2020